August 2, 2021
Via: The Medical NewsScientists in the Netherlands recently conducted an open-level, randomized-controlled trial to evaluate the safety and immunogenicity of fractional intradermal doses of the mRNA-based coronavirus disease 2019 (COVID-19) vaccine mRNA-1273 (Moderna). The trial findings reveal that the fractional dose regimen of […]